These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 21420032)
21. MicroRNAs: biogenesis, roles for carcinogenesis and as potential biomarkers for cancer diagnosis and prognosis. Kavitha N; Vijayarathna S; Jothy SL; Oon CE; Chen Y; Kanwar JR; Sasidharan S Asian Pac J Cancer Prev; 2014; 15(18):7489-97. PubMed ID: 25292018 [TBL] [Abstract][Full Text] [Related]
22. MicroRNAs in solid tumors. Dillhoff M; Wojcik SE; Bloomston M J Surg Res; 2009 Jun; 154(2):349-54. PubMed ID: 18656897 [TBL] [Abstract][Full Text] [Related]
23. MicroRNAs in personalized cancer therapy. Sethi S; Ali S; Sethi S; Sarkar FH Clin Genet; 2014 Jul; 86(1):68-73. PubMed ID: 24635652 [TBL] [Abstract][Full Text] [Related]
24. MicroRNAs in gastrointestinal malignancy: a tool in cancer prevention? Mactier KE; Glaire MA; Basavaraju U; El-Omar EM; Hold GL Eur J Cancer Prev; 2014 Nov; 23(6):540-9. PubMed ID: 24608603 [TBL] [Abstract][Full Text] [Related]
25. Multiple Roles of MicroRNA-100 in Human Cancer and its Therapeutic Potential. Li C; Gao Y; Zhang K; Chen J; Han S; Feng B; Wang R; Chen L Cell Physiol Biochem; 2015; 37(6):2143-59. PubMed ID: 26606597 [TBL] [Abstract][Full Text] [Related]
26. miRNAs as Potential Treatment Targets and Treatment Options in Cancer. Petrovic N; Ergun S Mol Diagn Ther; 2018 Apr; 22(2):157-168. PubMed ID: 29335927 [TBL] [Abstract][Full Text] [Related]
27. MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics. Gordanpour A; Nam RK; Sugar L; Seth A Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):314-9. PubMed ID: 22333688 [TBL] [Abstract][Full Text] [Related]
28. microRNAs: innovative targets for cerebral ischemia and stroke. Ouyang YB; Stary CM; Yang GY; Giffard R Curr Drug Targets; 2013 Jan; 14(1):90-101. PubMed ID: 23170800 [TBL] [Abstract][Full Text] [Related]
29. Breast cancer and microRNAs: therapeutic impact. Iorio MV; Casalini P; Piovan C; Braccioli L; Tagliabue E Breast; 2011 Oct; 20 Suppl 3():S63-70. PubMed ID: 22015296 [TBL] [Abstract][Full Text] [Related]
30. Challenges and opportunities of microRNAs in lymphomas. De Tullio G; De Fazio V; Sgherza N; Minoia C; Serratì S; Merchionne F; Loseto G; Iacobazzi A; Rana A; Petrillo P; Silvestris N; Iacopino P; Guarini A Molecules; 2014 Sep; 19(9):14723-81. PubMed ID: 25232701 [TBL] [Abstract][Full Text] [Related]
31. OncomicroRNAs-Mediated Tumorigenesis: Implication in Cancer Diagnosis and Targeted Therapy. Zheng N; Yang P; Wang Z; Zhou Q Curr Cancer Drug Targets; 2017; 17(1):40-47. PubMed ID: 26881930 [TBL] [Abstract][Full Text] [Related]
32. Nuclear microRNAs in normal hemopoiesis and cancer. Rasko JE; Wong JJ J Hematol Oncol; 2017 Jan; 10(1):8. PubMed ID: 28057040 [TBL] [Abstract][Full Text] [Related]
33. Oncogenesis and Tumor Inhibition by MicroRNAs and its Potential Therapeutic Applications: A Systematic Review. Karkhane M; Lashgarian HE; Hormozi M; Fallahi S; Cheraghipour K; Marzban A Microrna; 2020; 9(3):198-215. PubMed ID: 31686643 [TBL] [Abstract][Full Text] [Related]
34. MicroRNAs as therapeutic targets and their potential applications in cancer therapy. Cho WC Expert Opin Ther Targets; 2012 Aug; 16(8):747-59. PubMed ID: 22690697 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-124: An emerging therapeutic target in cancer. Jia X; Wang X; Guo X; Ji J; Lou G; Zhao J; Zhou W; Guo M; Zhang M; Li C; Tai S; Yu S Cancer Med; 2019 Sep; 8(12):5638-5650. PubMed ID: 31389160 [TBL] [Abstract][Full Text] [Related]
36. miRNAs in gastrointestinal and liver cancers: their perspectives and clinical applications. Shen J; Wu WK; Ren SX; Zhang L; Chan RL; Wong CC; Lu L; Cho CH Curr Pharm Des; 2013; 19(7):1301-10. PubMed ID: 23092341 [TBL] [Abstract][Full Text] [Related]
37. MicroRNAs in cancer: personalizing diagnosis and therapy. Nana-Sinkam SP; Fabbri M; Croce CM Ann N Y Acad Sci; 2010 Oct; 1210():25-33. PubMed ID: 20973796 [TBL] [Abstract][Full Text] [Related]
38. miRNA and cancer; computational and experimental approaches. Tutar Y Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575 [TBL] [Abstract][Full Text] [Related]
39. miRNAs in acute myeloid leukemia. Liao Q; Wang B; Li X; Jiang G Oncotarget; 2017 Jan; 8(2):3666-3682. PubMed ID: 27705921 [TBL] [Abstract][Full Text] [Related]
40. Contribution of bioinformatics prediction in microRNA-based cancer therapeutics. Banwait JK; Bastola DR Adv Drug Deliv Rev; 2015 Jan; 81():94-103. PubMed ID: 25450261 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]